[
    [
        {
            "time": "2019-07-31",
            "original_text": "AbbVie Inc (ABBV) Q2 2019 Earnings Call Transcript",
            "features": {
                "keywords": [
                    "Q2",
                    "Earnings",
                    "Call",
                    "Transcript"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "AbbVie Inc (ABBV) Q2 2019 Earnings Call Transcript",
                "Correlation": 10,
                "Sentiment": 6,
                "Importance": 9,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 5,
                "Headline_Structure": 5,
                "Source_Recency": 6
            }
        },
        {
            "time": "2019-07-31",
            "original_text": "AbbVie Earnings: ABBV Stock Pops on Q2 Beat",
            "features": {
                "keywords": [
                    "Earnings",
                    "Stock",
                    "Pops",
                    "Q2",
                    "Beat"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "AbbVie Earnings: ABBV Stock Pops on Q2 Beat",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-07-31",
            "original_text": "5 Things You Need to Know From AbbVie's Q2 Earnings Results",
            "features": {
                "keywords": [
                    "Things",
                    "Know",
                    "AbbVie",
                    "Q2",
                    "Earnings",
                    "Results"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "5 Things You Need to Know From AbbVie's Q2 Earnings Results",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "2019-07-31",
            "original_text": "AbbVie (ABBV) Beets on Q2 Earnings & Sales, Raises EPS View",
            "features": {
                "keywords": [
                    "AbbVie",
                    "Beats",
                    "Q2",
                    "Earnings",
                    "Sales",
                    "EPS",
                    "View"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "AbbVie (ABBV) Beets on Q2 Earnings & Sales, Raises EPS View",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-07-31",
            "original_text": "Bristol-Myers Squibb (BMY) Catches Eye: Stock Jumps 5%",
            "features": {
                "keywords": [
                    "Bristol-Myers",
                    "Squibb",
                    "Stock",
                    "Jumps"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Bristol-Myers Squibb (BMY) Catches Eye: Stock Jumps 5%",
                "Correlation": 3,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 5,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-07-31",
            "original_text": "AbbVie Discontinued a Drug Trial. Biogen Stock Is Falling.",
            "features": {
                "keywords": [
                    "AbbVie",
                    "Discontinued",
                    "Drug",
                    "Trial",
                    "Biogen",
                    "Stock",
                    "Falling"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "AbbVie Discontinued a Drug Trial. Biogen Stock Is Falling.",
                "Correlation": 5,
                "Sentiment": 3,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 6,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2019-07-31",
            "original_text": "AbbVie spotlights Allergan deal, new drugs as Humira sales wane",
            "features": {
                "keywords": [
                    "AbbVie",
                    "Allergan",
                    "deal",
                    "new",
                    "drugs",
                    "Humira",
                    "sales",
                    "wane"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "AbbVie spotlights Allergan deal, new drugs as Humira sales wane",
                "Correlation": 10,
                "Sentiment": 6,
                "Importance": 9,
                "Impact": 7,
                "Duration": 9,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2019-07-31",
            "original_text": "AstraZeneca (AZN) Jumps: Stock Rises 5.7%",
            "features": {
                "keywords": [
                    "AstraZeneca",
                    "Jumps",
                    "Stock",
                    "Rises"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "AstraZeneca (AZN) Jumps: Stock Rises 5.7%",
                "Correlation": 2,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-07-31",
            "original_text": "AbbVie (ABBV) Toppes Q2 Earnings and Revenue Estimates",
            "features": {
                "keywords": [
                    "AbbVie",
                    "Tops",
                    "Q2",
                    "Earnings",
                    "Revenue",
                    "Estimates"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "AbbVie (ABBV) Toppes Q2 Earnings and Revenue Estimates",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-07-31",
            "original_text": "AbbVie Reverses 4-Day Dive — But Its Biggest Moneymaker Is In Trouble",
            "features": {
                "keywords": [
                    "AbbVie",
                    "Reverses",
                    "4-Day",
                    "Dive",
                    "Biggest",
                    "Moneymaker",
                    "Trouble"
                ],
                "sentiment_score": -0.4,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "AbbVie Reverses 4-Day Dive — But Its Biggest Moneymaker Is In Trouble",
                "Correlation": 10,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        }
    ]
]